Poor outcome in postpartum breast cancer patients is associated with distinct molecular and immunological features. Lefrere H, Moore K, Floris G, Sanders J, et al. Clin Cancer Res 2023 Jul 14:CCR-22-3645. doi: 10.1158/1078-0432.CCR-22-3645.

Read + Share

Amedeo Smart

Independent Medical Education

Lefrere H, Moore K, Floris G, Sanders J, et al. Poor outcome in postpartum breast cancer patients is associated with distinct molecular and immunological features. Clin Cancer Res 2023 Jul 14:CCR-22-3645. doi: 10.1158/1078-0432.CCR-22-3645.
PMID: 37449970